+Search query
-Structure paper
Title | Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology. |
---|---|
Journal, issue, pages | J. Biol. Chem., Vol. 295, Page 17935-17949, Year 2020 |
Publish date | May 17, 2018 (structure data deposition date) |
Authors | Ladds, M.J.G.W. / Popova, G. / Pastor-Fernandez, A. / Kannan, S. / van Leeuwen, I.M.M. / Hakansson, M. / Walse, B. / Tholander, F. / Bhatia, R. / Verma, C.S. ...Ladds, M.J.G.W. / Popova, G. / Pastor-Fernandez, A. / Kannan, S. / van Leeuwen, I.M.M. / Hakansson, M. / Walse, B. / Tholander, F. / Bhatia, R. / Verma, C.S. / Lane, D.P. / Lain, S. |
External links | J. Biol. Chem. / PubMed:32900849 |
Methods | X-ray diffraction |
Resolution | 1.85 Å |
Structure data | PDB-6gk0: |
Chemicals | ChemComp-FMN: ChemComp-DOR: ChemComp-ACY: ChemComp-GOL: ChemComp-SO4: ChemComp-CL: ChemComp-DDQ: ChemComp-F1W: ChemComp-HOH: |
Source |
|
Keywords | ANTITUMOR PROTEIN / Dehydrogenase DHODH tumor-killing drug development |